Study of the Safety and Efficacy of MK-8521 Compared to Placebo and a Diabetes Drug in Participants With Type 2 Diabetes Mellitus (MK-8521-003)

Clinical trial NCT01982630 · COMPLETED

Trial details

NCT number

NCT01982630

Sponsor

Merck Sharp & Dohme LLC

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2013-11-07

Primary completion

2014-10-03

Enrollment

87

View on ClinicalTrials.gov